Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Horizon Wins Approval For Rayos Rheumatoid Arthritis Drug
Bloomberg
Thursday, July 26, 2012 - 10:54pm
tags:
Rayos, rheumatoid arthritis, Horizon Pharma, FDA
Amarin Wins Approval For Debut Drug To Treat High Blood Fats
Bloomberg
Thursday, July 26, 2012 - 10:50pm
tags:
Amarin, FDA, fish oil, AMR101, Vascepa
Sanofi posts slower Q2 drop, keeps 2012 outlook
Reuters
Thursday, July 26, 2012 - 11:07am
tags:
earnings, Sanofi
Eli Lilly and Company Earnings Call INSIGHTS: Insulin Numbers, Prudent Expense Management
Wall St. Cheat Sheet
Thursday, July 26, 2012 - 11:02am
tags:
earnings, Eli Lilly
Pfizer Needs Big Earnings Beat
TheStreet.com
Thursday, July 26, 2012 - 10:37am
tags:
earnings, Pfizer
Sanofi CEO Pledges ‘Thoughtful’ Job Cuts To Avoid Peugeot Drama
Bloomberg
Thursday, July 26, 2012 - 10:34am
tags:
Chris Viehbacher, Sanofi, layoffs, reorganization
Roche First-Half Profit Drops on Costs to Shut N.J. Site
Bloomberg
Thursday, July 26, 2012 - 10:13am
tags:
earnings, Roche
In Conversations About Potential To Treat Alzheimer's, Don't Forget Baxter's Gammagard
Forbes
Thursday, July 26, 2012 - 10:11am
tags:
Baxter, Alzheimer's disease, Gammagard
AMRN FDA Approval Likely Today
Forbes
Thursday, July 26, 2012 - 10:09am
tags:
FDA, Amarin, AMR101, fish oil
Pluristem, NIH to study stem cells to treat radiation syndrome
Reuters
Thursday, July 26, 2012 - 9:30am
tags:
Pluristem, NIH, stem cells, radiation syndrome
Generics knock AstraZeneca Q2 earnings by 24 pct
Yahoo/AP
Thursday, July 26, 2012 - 9:24am
tags:
earnings, AstraZeneca
Glaxo sales slump in Europe, U.S. on price cuts, generics
Fierce Pharma
Wednesday, July 25, 2012 - 11:42pm
tags:
GSK, earnings
FDA ravages Sanofi vaccine sterility process in warning letter
Fierce Pharma Manufacturing
Wednesday, July 25, 2012 - 11:37pm
tags:
Sanofi, vaccines, drug manufacturing, FDA, warnings
Alexion Smashes Street's Estimates As Soliris Shines
Investors.com
Wednesday, July 25, 2012 - 11:35pm
tags:
Soliris, Alexion, earnings
IPO Preview: Hyperion Therapeutics
Seeking Alpha
Wednesday, July 25, 2012 - 11:33pm
tags:
Hyperion Therapeutics, IPOs
GlaxoSmithKline's R&D Is Delivering, But The Street's Not Buying
Seeking Alpha
Wednesday, July 25, 2012 - 11:32pm
tags:
R&D, GSK, Pfizer, Theravance, Human Genome Sciences, Gilead
‘Pay-for-Delay’ Drug Case Moves Forward
NY Times, NY
Wednesday, July 25, 2012 - 11:27pm
tags:
pay-for-delay, Lundbeck, Europe
AIDS Cure Quest Advances As Cancer Drug Finds Hidden HIV
Bloomberg
Wednesday, July 25, 2012 - 11:19pm
tags:
HIV, AIDS, Merck, Zolinza
Will the FDA Approve Amarin's AMR101?
Motley Fool
Wednesday, July 25, 2012 - 11:15pm
tags:
fish oil, FDA, AMR101, Amarin
Can Vivus Inc. Ride Qsymia to Market Success and Big Returns?
Insider Monkey
Wednesday, July 25, 2012 - 9:49am
tags:
Vivus, Qsymia, obesity

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.